China Botanical and Plant Derived Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 21-Dec-2021
No. of pages: 90
Inquire Before Buying

China Botanical and Plant Derived Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Botanical and Plant Derived Drugs Market Segment Percentages, By Type, 2020 (%)

- Tablets

- Capsules

- Pills

- Injections

China Botanical and Plant Derived Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Botanical and Plant Derived Drugs Market Segment Percentages, By Application, 2020 (%)

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Drug Stores

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Botanical and Plant Derived Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Botanical and Plant Derived Drugs revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abott Laboratories

- Bayer Healthcare

- Bionova

- Bristol Myers

- Curapharm

China Botanical and Plant Derived Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Botanical and Plant Derived Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Botanical and Plant Derived Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Botanical and Plant Derived Drugs Overall Market Size
2.1 China Botanical and Plant Derived Drugs Market Size: 2021 VS 2027
2.2 China Botanical and Plant Derived Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Botanical and Plant Derived Drugs Players in China Market
3.2 Top China Botanical and Plant Derived Drugs Companies Ranked by Revenue
3.3 China Botanical and Plant Derived Drugs Revenue by Companies
3.4 Top 3 and Top 5 Botanical and Plant Derived Drugs Companies in China Market, by Revenue in 2020
3.5 Companies Botanical and Plant Derived Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Botanical and Plant Derived Drugs Players in China Market
3.6.1 List of Tier 1 Botanical and Plant Derived Drugs Companies in China
3.6.2 List of Tier 2 and Tier 3 Botanical and Plant Derived Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Botanical and Plant Derived Drugs Market Size Markets, 2021 & 2027
4.1.2 Tablets
4.1.3 Capsules
4.1.4 Pills
4.1.5 Injections
4.2 By Type - China Botanical and Plant Derived Drugs Revenue & Forecasts
4.2.1 By Type - China Botanical and Plant Derived Drugs Revenue, 2016-2021
4.2.2 By Type - China Botanical and Plant Derived Drugs Revenue, 2022-2027
4.2.3 By Type - China Botanical and Plant Derived Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Botanical and Plant Derived Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Drug Stores
5.2 By Application - China Botanical and Plant Derived Drugs Revenue & Forecasts
5.2.1 By Application - China Botanical and Plant Derived Drugs Revenue, 2016-2021
5.2.2 By Application - China Botanical and Plant Derived Drugs Revenue, 2022-2027
5.2.3 By Application - China Botanical and Plant Derived Drugs Revenue Market Share, 2016-2027
6 Botanical and Plant Derived Drugs Companies Profiles
6.1 Abott Laboratories
6.1.1 Abott Laboratories Company Details
6.1.2 Abott Laboratories Business Overview
6.1.3 Abott Laboratories Botanical and Plant Derived Drugs Introduction
6.1.4 Abott Laboratories Botanical and Plant Derived Drugs Revenue in China Market (2016-2021)
6.1.5 Abott Laboratories Recent Developments
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Company Details
6.2.2 Bayer Healthcare Business Overview
6.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Introduction
6.2.4 Bayer Healthcare Botanical and Plant Derived Drugs Revenue in China Market (2016-2021)
6.2.5 Bayer Healthcare Recent Developments
6.3 Bionova
6.3.1 Bionova Company Details
6.3.2 Bionova Business Overview
6.3.3 Bionova Botanical and Plant Derived Drugs Introduction
6.3.4 Bionova Botanical and Plant Derived Drugs Revenue in China Market (2016-2021)
6.3.5 Bionova Recent Developments
6.4 Bristol Myers
6.4.1 Bristol Myers Company Details
6.4.2 Bristol Myers Business Overview
6.4.3 Bristol Myers Botanical and Plant Derived Drugs Introduction
6.4.4 Bristol Myers Botanical and Plant Derived Drugs Revenue in China Market (2016-2021)
6.4.5 Bristol Myers Recent Developments
6.5 Curapharm
6.5.1 Curapharm Company Details
6.5.2 Curapharm Business Overview
6.5.3 Curapharm Botanical and Plant Derived Drugs Introduction
6.5.4 Curapharm Botanical and Plant Derived Drugs Revenue in China Market (2016-2021)
6.5.5 Curapharm Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Botanical and Plant Derived Drugs Market Opportunities & Trends in China Market
Table 2. Botanical and Plant Derived Drugs Market Drivers in China Market
Table 3. Botanical and Plant Derived Drugs Market Restraints in China Market
Table 4. Key Players of Botanical and Plant Derived Drugs in China Market
Table 5. Top Botanical and Plant Derived Drugs Players in China Market, Ranking by Revenue (2019)
Table 6. China Botanical and Plant Derived Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Botanical and Plant Derived Drugs Revenue Share by Companies, 2016-2021
Table 8. Companies Botanical and Plant Derived Drugs Product Type
Table 9. List of Tier 1 Botanical and Plant Derived Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Botanical and Plant Derived Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Botanical and Plant Derived Drugs Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Botanical and Plant Derived Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Botanical and Plant Derived Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Botanical and Plant Derived Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Botanical and Plant Derived Drugs Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Botanical and Plant Derived Drugs Revenue (US$, Mn), 2022-2027
Table 17. Abott Laboratories Company Details
Table 18. Abott Laboratories Business Overview
Table 19. Abott Laboratories Botanical and Plant Derived Drugs Product
Table 20. Abott Laboratories Botanical and Plant Derived Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Abott Laboratories Recent Developments
Table 22. Bayer Healthcare Company Details
Table 23. Bayer Healthcare Business Overview
Table 24. Bayer Healthcare Botanical and Plant Derived Drugs Product
Table 25. Bayer Healthcare Botanical and Plant Derived Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Bayer Healthcare Recent Developments
Table 27. Bionova Company Details
Table 28. Bionova Business Overview
Table 29. Bionova Botanical and Plant Derived Drugs Product
Table 30. Bionova Botanical and Plant Derived Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Bionova Recent Developments
Table 32. Bristol Myers Company Details
Table 33. Bristol Myers Business Overview
Table 34. Bristol Myers Botanical and Plant Derived Drugs Product
Table 35. Bristol Myers Botanical and Plant Derived Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Bristol Myers Recent Developments
Table 37. Curapharm Company Details
Table 38. Curapharm Business Overview
Table 39. Curapharm Botanical and Plant Derived Drugs Product
Table 40. Curapharm Botanical and Plant Derived Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Curapharm Recent Developments
List of Figures
Figure 1. Botanical and Plant Derived Drugs Segment by Type
Figure 2. Botanical and Plant Derived Drugs Segment by Application
Figure 3. China Botanical and Plant Derived Drugs Market Overview: 2020
Figure 4. China Botanical and Plant Derived Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Botanical and Plant Derived Drugs Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Botanical and Plant Derived Drugs Revenue in 2020
Figure 7. By Type - China Botanical and Plant Derived Drugs Revenue Market Share, 2016-2027
Figure 8. By Application - China Botanical and Plant Derived Drugs Revenue Market Share, 2016-2027
Figure 9. Abott Laboratories Botanical and Plant Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Bayer Healthcare Botanical and Plant Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bionova Botanical and Plant Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Bristol Myers Botanical and Plant Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Curapharm Botanical and Plant Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs